Spots Global Cancer Trial Database for philadelphia chromosome positive acute (ph+all)
Every month we try and update this database with for philadelphia chromosome positive acute (ph+all) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia | NCT00103701 | Leukemia, Myelo... Leukemia, Lymph... | Dasatinib | 14 Years - | Bristol-Myers Squibb | |
| BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia | NCT00103701 | Leukemia, Myelo... Leukemia, Lymph... | Dasatinib | 14 Years - | Bristol-Myers Squibb | |
| BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia | NCT00103701 | Leukemia, Myelo... Leukemia, Lymph... | Dasatinib | 14 Years - | Bristol-Myers Squibb |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
